Medulloblastoma: Molecular Targets and Innovative Theranostic Approaches

Area of Science:

• Oncology
• Nanotechnology
• Pharmacology

Background:

• Medulloblastoma is a rare pediatric brain tumor with limited treatment options.
• Current therapies face challenges like toxicity, resistance, and lack of specificity.
• Molecular subgroups of medulloblastoma necessitate targeted therapeutic strategies.

Purpose of the Study:

• To review the role of nanomedicine in treating pediatric medulloblastoma.
• To explore theranostic nanoplatforms for targeted drug delivery and imaging.
• To highlight nanomedicine's potential in personalized medicine for medulloblastoma.

Main Methods:

• Chronological literature analysis of major web-based research platforms.
• Focus on molecular targets and nanomedicine applications.
• Review of nanoparticle-based drug delivery and imaging agents.

Main Results:

• Nanoparticle systems enable selective targeting, improving efficacy and reducing side effects.
• Nanotechnology-based imaging agents enhance diagnostic accuracy and treatment monitoring.
• Key challenges include the blood-brain barrier, biocompatibility, and regulatory approval.

Conclusions:

• Nanomedicine shows promise for personalized medulloblastoma treatment.
• Theranostic nanoplatforms can merge diagnosis and therapy.
• Future research should focus on developing novel nanoplatforms for clinical application.